文献速递区域麻醉与超声疼痛医学

神经周围与静脉地塞米松对低容量肌间沟臂丛阻滞影响的等效性随机试验比较

Comparison of the effects of perineural or intravenous dexamethasone on low volume interscalene brachial plexus block: a randomised equivalence trial.
PubMed 文献 · Br J Anaesth · 2019-10-05

本研究将182例择期肩关节镜手术患者随机分为肌间沟臂丛阻滞(ISB)采用0.5%罗哌卡因5 ml复合神经周围或静脉地塞米松4 mg两组,主要结局为镇痛持续时间,采用等效性检验(等效界值2小时)。结果显示两组镇痛持续时间不等效,但平均阻滞时间差异无临床相关性(静脉组延长0.75小时),其他临床结局无显著差异。

要点

  • 低容量ISB中神经周围与静脉地塞米松对镇痛持续时间不等效。
  • 静脉地塞米松组阻滞时间平均延长0.75小时,无临床相关性。
  • 两组其他临床结局无显著差异,神经周围给药无优势。

核心结论

  • 在低容量ISB复合罗哌卡因时,神经周围与静脉地塞米松对阻滞持续时间的影响不等效。
  • 但两组结局无临床显著差异,神经周围给药并不优于静脉给药。

研究设计与样本

  • 随机等效性试验,纳入182例择期肩关节镜手术患者。
  • 患者随机接受0.5%罗哌卡因5 ml ISB复合神经周围或静脉地塞米松4 mg,受试者、麻醉科医师和研究人员均设盲。
  • 所有患者接受标准化全身麻醉和多模式镇痛,主要结局为镇痛持续时间,采用双单侧检验(TOST)方法,等效界值2小时。

主要发现

  • 主要结局镇痛持续时间两组不等效:90%置信区间上限为1小时(P=0.12),下限为-2.5小时(P=0.01)。
  • 平均阻滞时间差异无临床相关性,静脉地塞米松组延长0.75小时。
  • 两组间无其他临床显著差异。

关键数值与推荐

  • 等效性界值为2小时,采用双单侧检验(TOST)方法分析。
  • 神经周围与静脉地塞米松4 mg在0.5%罗哌卡因5 ml ISB下镇痛持续时间不等效。

临床怎么用

  • 临床可考虑静脉给予地塞米松4 mg作为低容量ISB的辅助,以避免神经周围给药的超说明书使用。
  • 神经周围地塞米松并无临床优势,选择给药途径时应权衡利弊。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Efforts to prolong interscalene block (ISB) analgesia include the use of local anaesthetic adjuvants such as dexamethasone. Previous work showing prolonged block duration suggests that both perineural and intravenous (i.v.) routes can both prolong analgesia. The superiority of either route is controversial given the design of previous studies. As perineural dexamethasone is an off-label use, anaesthesiologists should be fully informed of the clinical differences, if any, on block duration. This study was designed to test whether perineural vs i.v. dexamethasone administration are equivalent. METHODS: We randomised 182 eligible patients scheduled for arthroscopic shoulder surgery to receive low-dose ISB (0.5% ropivacaine 5 ml) with perineural or i.v. dexamethasone 4 mg. Subjects, anaesthesiologists, and research personnel were blinded. All subjects also received a standardised general anaesthetic and multimodal analgesia. The primary outcome was duration of analgesia analysed as an equivalence outcome (2 h equivalency margin) using the two one-sided test (TOST) method. RESULTS: For the primary outcome, duration of analgesia, and perineural and i.v. administration of dexamethasone were not equivalent. The upper and lower bounds of the 90% confidence interval were 1 h (P=0.12) and -2.5 h (P=0.01), respectively. The observed difference in mean block duration was not clinically relevant (0.75 h longer for i.v. dexamethasone). There were no other clinically significant differences between groups. CONCLUSION: In the context of low-volume ISB with ropivacaine, perineural and i.v. dexamethasone were not equivalent in terms of their effects on block duration. However, there were no clinically significant differences in outcomes, and there is no advantage of perineural over intravenous dexamethasone. WWW.CLINICALTRIALS. GOV REGISTRATION: NCT02322242.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. McHardy PG, Singer O, Awad IT, et al. Comparison of the effects of perineural or intravenous dexamethasone on low volume interscalene brachial plexus block: a randomised equivalence trial. Br J Anaesth. 2019. PMID: 31591018. doi:10.1016/j.bja.2019.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。